US$28.5MILLION BUSINESS PROPOSAL

It is my profound intention to make this mutually benefiting but
confidential business proposal to you. My name is Engr. Philip Ezoma the
Contract Award Committee Chairman in the Nigerian National Petroleum
Cooperation (NNPC). I know that this proposal may come to you as a
surprise, but I would like to appeal for your co-operation to enable us
secure an approval on your behalf for a total sum of US$28.5Million being
an over invoiced contract amount to be transferred to your nominated bank
account for our mutual benefit.
Early last year there was a major oil spillage in the Niger Delta Region
of Nigeria which rendered over 70% of the communities homeless. So the
federal government decided to lease the three existing petroleum
refineries to private individuals and companies to make the refineries
more viable, resourceful and to eliminate undue wastage and fraud. So
contracts were awarded to a foreign firm for the repair and construction
of new refineries, but because of the huge monetary profit we envisaged we
decided to over-invoice the contract sum. The real contract value was
US$91.5Million, but it was over estimated to the tune of US$120Million.
Now the contract has been completed and the original contractor has since
been paid, but the contract balance of US$28.5Million, which resulted from
the over invoiced contract sum is been left in a suspense account with the
CENTRAL BANK corresponding paying bank in Europe.
I have been assigned by my other colleagues to seek for assistance of a
reliable foreigner through whom we can transfer this sum of US$28.5Million
which arose from the deliberate over-inflated contract value. It does not
matter whether you or your company does contract project of the nature
described here, but the assumption is that you won a major contract and
subcontracted it to another company, more often non big trading companies
or individuals of unrelated field win major contracts here and
subcontracts same to more specialized firms for execution. So the nature
of your business is not particularly relevant for the success of this
transaction. All we require is your willingness as a foreigner to
co-operate with us and assurance that our own share will be given to us
when this money is transferred into your account. Then we shall use our
position to secure all the government approvals in your favor to enable
the transfer of the remaining 28.5Million to your nominated bank account.
We have agreed that you will be entitled to 25% of the entire funds, 70%
will be for us, while 5% will be set aside to cover any unforeseen
expenses that may be incurred by both parties during this transaction,
both local and international.
Please I enjoin you to handle this message with utmost degree of maturity
and confidentiality because I am still in active government service with
the NIGERIAN NATIONAL PETROLEUM CORPORATION. All necessary precautions
have been taken to ensure a no risk situation on the sides of both parties
and it is believed that the conclusion of this transaction will not last
more than 8 working days, since the money is already in transit account
with the corresponding paying bank in Europe. However, we are going to
retrieve the whole documents that will relate to this transaction after
the transfer of the money into your account to avoid any trace of the
money.
I will call you when I receive your direct telephone number to discuss
this more with you and also send you all the details immediately as I
receive your reply.
Please treat as very confidential matter and please reply me only to:
nnpc.contractaward@ibibo.com
Much Regards,
Engr. Philip Ezoma

U.S. Food & Drug Administration (FDA) Daily Digest Bulletin

You have requested to receive a Daily Digest e-mail from U.S. Food & Drug Administration (FDA).

Message: 1
From: "U.S. Food & Drug Administration (FDA)" <fda@service.govdelivery.com>
Date: Mon, 23 Jun 2008 06:00:46 -0500 (CDT)
Subject: CDRH New Update

	FDA Home Page | CDRH Home Page | Search | A-Z Index

Date: June 23, 2008

The following new items were added to the CDRH web pages on June 20, 2008. Previous CDRH New Items can be found on the CDRHNew Page.

Office of Device Evaluation (ODE) Fiscal Year 2006 and Fiscal Year 2007 Annual Report

---

Message: 2
From: "U.S. Food & Drug Administration (FDA)" <fda@service.govdelivery.com>
Date: Mon, 23 Jun 2008 17:03:36 -0500 (CDT)
Subject: Fresca Italia, Inc., Expands Recall of Burrata Cheese Because of Possible Health Risk (June 23)

Fresca Italia, Inc., Expands Recall of Burrata Cheese Because of Possible Health Risk (June 23)
Mon, 23 Jun 2008 16:23:00 -0500

Fresca Italia is recalling Burrata, a type of cheese, because it has the potential to be contaminated with Listeria monocytogenes, an organism which can cause serious infections in young children, frail or elderly people, and others with weakened immune systems. Although healthy individuals may suffer only short-term symptoms such as fever, headache, stiffness, nausea, abdominal, or diarrhea, listeria infection can cause miscarriages and stillbirths among pregnant women.

---

Message: 3
From: "U.S. Food & Drug Administration (FDA)" <fda@service.govdelivery.com>
Date: Mon, 23 Jun 2008 12:37:28 -0500 (CDT)
Subject: FDA MedWatch - February 2008 Drug Safety Labeling Changes for 47 drugs now available on web

The February 2008 posting includes 47 drug products with safety labeling changes to the following sections: BOXED WARNING, CONTRAINDICATIONS, WARNINGS, PRECAUTIONS, ADVERSE REACTIONS, and PATIENT PACKAGE INSERTS, and MEDICATION GUIDES.

The Summary Page provides a listing of drug names and safety labeling sections revised: http://www.fda.gov/medwatch/SAFETY/2008/feb08_quickview.htm

The Detailed View Page identifies safety labeling sections and subsections revised along with a brief summary of new or modified safety information to the BOXED WARNING, CONTRAINDICATIONS, and/or WARNINGS sections: http://www.fda.gov/medwatch/SAFETY/2008/feb08.htm

In February 2008, the following drugs had modifications to the BOXED WARNING, CONTRAINDICATIONS, and/or WARNINGS sections:

Atripla (efavirenz 600 mg/emtricitabine 200 mg/tenofovir disoproxil fumarate 300 mg) Tablets

Cleocin Sterile Solution (clindamycin injection)

Cleocin Phosphate (clindamycin injection in 5% dextrose) IV Sterile Solution

Duragesic (fentanyl) Transdermal System

Emsam (selegiline transdermal system) Patches

Fentora (fentanyl buccal tablet)

Lincocin (lincomycin) Injection

Asmanex Twisthaler (mometasone furoate inhalation powder)

Abilify (aripiprazole) Tablets and Oral Solution

Abilify (aripiprazole) Discmelt Orally Disintegrating Tablets

Abilify (aripiprazole) Injection for Intramuscular Use Only

Avastin (bevacizumab) for Intravenous Use

Claforan Sterile (cefotaxime sodium for injection, USP) and Injection (cefotaxime sodium injection, USP)

Cortenema (hydrocortisone retention enema)

Doryx (doxycycline hyclate) Capsule, Delayed Release Pellets

Eryc (erythromycin delayed-release capsules, USP)

Erythrocin Lactobinate (erythromycin lactobionate) Injection, Powder, Lyophilized, For Solution

Geocillin (carbenicillin indanyl sodium) Tablets

Halcion (triazolam tablets)

Janumet (sitagliptin/metformin HCl) Tablets

Letairis (ambrisentan) Tablets

Premarin Intravenous (conjugated estrogens, USP) for injection

Remodulin (treprostinil sodium) Injection

Restoril (temazepam) Capsules

Reyataz (atazanavir sulfate) Capsules 

Sensipar (cinacalcet) Tablets

Ultram ER (tramadol HCl) Extended-Release Tablets

Vibramycin Calcium (doxycycline calcium oral suspension, USP) Oral Suspension Syrup

Vibramycin Hyclate (doxycycline hyclate capsules, USP) Capsules

Vibramycin Monohydrate (doxycycline monohydrate) for Oral Suspension

Vibra-Tabs (doxycycline hyclate tablets, USP) Film Coated Tablets

---

Update your subscriptions, modify your e-mail address, or stop subscriptions at any time on your Subscriber Preferences Page. You will need to use your e-mail address to log in. If you have questions or problems with the subscription service, please contact support@govdelivery.com.

This service is provided to you at no charge by U.S. Food & Drug Administration (FDA).

GovDelivery, Inc. sending on behalf of U.S. Food & Drug Administration (FDA) · 5600 Fishers Lane · Rockville MD 20857 · 800-439-1420

U.S. Food & Drug Administration (FDA) Daily Digest Bulletin

You have requested to receive a Daily Digest e-mail from U.S. Food & Drug Administration (FDA).

Message: 1
From: "U.S. Food & Drug Administration (FDA)" <fda@service.govdelivery.com>
Date: Fri, 20 Jun 2008 05:34:29 -0500 (CDT)
Subject: CDRH New Update

	FDA Home Page | CDRH Home Page | Search | A-Z Index

Date: June 20, 2008

The following new items were added to the CDRH web pages on June 19, 2008. Previous CDRH New Items can be found on the CDRHNew Page.

	Federal Register: Medical Devices; Technical Amendment.
	Ophthalmic Devices Panel Advisory Meeting, June 10, 2008 - Slides

---

Update your subscriptions, modify your e-mail address, or stop subscriptions at any time on your Subscriber Preferences Page. You will need to use your e-mail address to log in. If you have questions or problems with the subscription service, please contact support@govdelivery.com.

This service is provided to you at no charge by U.S. Food & Drug Administration (FDA).

GovDelivery, Inc. sending on behalf of U.S. Food & Drug Administration (FDA) · 5600 Fishers Lane · Rockville MD 20857 · 800-439-1420

U.S. Food & Drug Administration (FDA) Daily Digest Bulletin

You have requested to receive a Daily Digest e-mail from U.S. Food & Drug Administration (FDA).

Message: 1
From: "U.S. Food & Drug Administration (FDA)" <fda@service.govdelivery.com>
Date: Thu, 19 Jun 2008 16:05:07 -0500 (CDT)
Subject: FDA Requests Seizure of Animal Food Products at PETCO Distribution Center

FDA Requests Seizure of Animal Food Products at PETCO Distribution Center
Thu, 19 Jun 2008 15:23:00 -0500

At the request of the U.S. Food and Drug Administration (FDA), U.S. Marshals seized various animal food products stored under unsanitary conditions at the PETCO Animal Supplies Distribution Center located in Joliet, Ill., pursuant to a warrant issued by the United States District Court in Chicago.

---

Update your subscriptions, modify your e-mail address, or stop subscriptions at any time on your Subscriber Preferences Page. You will need to use your e-mail address to log in. If you have questions or problems with the subscription service, please contact support@govdelivery.com.

This service is provided to you at no charge by U.S. Food & Drug Administration (FDA).

GovDelivery, Inc. sending on behalf of U.S. Food & Drug Administration (FDA) · 5600 Fishers Lane · Rockville MD 20857 · 800-439-1420

U.S. Food & Drug Administration (FDA) Daily Digest Bulletin

You have requested to receive a Daily Digest e-mail from U.S. Food & Drug Administration (FDA).

Message: 1
From: "U.S. Food & Drug Administration (FDA)" <fda@service.govdelivery.com>
Date: Wed, 18 Jun 2008 06:28:56 -0500 (CDT)
Subject: CDRH New Update

	FDA Home Page | CDRH Home Page | Search | A-Z Index

Date: June 18, 2008

The following new items were added to the CDRH web pages on June 17, 2008. Previous CDRH New Items can be found on the CDRHNew Page.

Office of Science and Engineering Laboratories (OSEL) Fiscal Year 2007 Annual Report

---

Message: 2
From: "U.S. Food & Drug Administration (FDA)" <fda@service.govdelivery.com>
Date: Wed, 18 Jun 2008 09:06:56 -0500 (CDT)
Subject: FDA Warning Letters Update

You are subscribed to FDA Warning Letters for U.S. Food & Drug Administration (FDA). This information has recently been updated, and is now available.

---

Message: 3
From: "U.S. Food & Drug Administration (FDA)" <fda@service.govdelivery.com>
Date: Wed, 18 Jun 2008 10:04:57 -0500 (CDT)
Subject: FDA Approves Diaphragm-Pacing Device

FDA Approves Diaphragm-Pacing Device
Wed, 18 Jun 2008 09:17:00 -0500

The U.S. Food and Drug Administration today announced that it approved the NeuRx DPS RA/4 Respiratory Stimulation System, an implantable electronic device that stimulates the diaphragm and allows certain spinal cord injury patients to breathe for at least four hours a day without a mechanical ventilator.

---

Message: 4
From: "U.S. Food & Drug Administration (FDA)" <fda@service.govdelivery.com>
Date: Wed, 18 Jun 2008 12:05:01 -0500 (CDT)
Subject: United States and China Outline Progress on Agreement on Food and Feed Safety (HHS Release)

United States and China Outline Progress on Agreement on Food and Feed Safety (HHS Release)
Wed, 18 Jun 2008 11:28:00 -0500

U.S. Secretary of Health and Human Services (HHS) Mike Leavitt signed a Joint Progress Statement today with the Honorable Li Changjiang, Minister of the General Administration of Quality Supervision, Inspection, and Quarantine (AQSIQ) of the People’s Republic of China. The document outlines steps taken by both nations in implementing the 2007 Memorandum of Agreement (MOA) on food and feed safety.

---

Update your subscriptions, modify your e-mail address, or stop subscriptions at any time on your Subscriber Preferences Page. You will need to use your e-mail address to log in. If you have questions or problems with the subscription service, please contact support@govdelivery.com.

This service is provided to you at no charge by U.S. Food & Drug Administration (FDA).

GovDelivery, Inc. sending on behalf of U.S. Food & Drug Administration (FDA) · 5600 Fishers Lane · Rockville MD 20857 · 800-439-1420

U.S. Food & Drug Administration (FDA) Daily Digest Bulletin

You have requested to receive a Daily Digest e-mail from U.S. Food & Drug Administration (FDA).

Message: 1
From: "U.S. Food & Drug Administration (FDA)" <fda@service.govdelivery.com>
Date: Tue, 17 Jun 2008 10:05:46 -0500 (CDT)
Subject: FDA Warns Individuals and Firms to Stop Selling Fake Cancer 'Cures'

FDA Warns Individuals and Firms to Stop Selling Fake Cancer 'Cures'
Tue, 17 Jun 2008 09:30:00 -0500

Warning Letters have been sent to 23 U.S. companies and two foreign individuals marketing a wide range of products fraudulently claiming to prevent and cure cancer, according to the U.S. Food and Drug Administration today. The FDA also warns North American consumers against using or purchasing the products, which include tablets, teas, tonics, black salves, and creams, and are sold under various names on the Internet.

---

Message: 2
From: "U.S. Food & Drug Administration (FDA)" <fda@service.govdelivery.com>
Date: Tue, 17 Jun 2008 12:49:20 -0500 (CDT)
Subject: Recent Device Approvals: Biotronik Left Ventricular Pacing Leads

You are subscribed to Recent Device Approvals updates for U.S. Food & Drug Administration (FDA). Information about Biotronik's Stratos LV and Stratos LV T CRT Ps and Corox OTW BP and Corox OTW S BP Left Ventricular Pacing Leads has recently been posted to the FDA website, and is now available.

---

Message: 3
From: "U.S. Food & Drug Administration (FDA)" <fda@service.govdelivery.com>
Date: Tue, 17 Jun 2008 19:03:58 -0500 (CDT)
Subject: Tipu's Tiger Chai, Inc Recalls Tipus Tiger Chai Concentrate Because of a Possible Health Risk (June 17)

Tipu's Tiger Chai, Inc Recalls Tipus Tiger Chai Concentrate Because of a Possible Health Risk (June 17)
Tue, 17 Jun 2008 18:48:00 -0500

Tipu's Tiger Chai Inc, of Missoula, Montana is voluntarily recalling its Tipu's Tiger Chai Concentrate because it has the potential to be contaminated with Clostridium botulinum, a bacterium which can cause life-threatening illness or death. Consumers are warned not to use the product even if it does not look or smell spoiled.

---

Update your subscriptions, modify your e-mail address, or stop subscriptions at any time on your Subscriber Preferences Page. You will need to use your e-mail address to log in. If you have questions or problems with the subscription service, please contact support@govdelivery.com.

This service is provided to you at no charge by U.S. Food & Drug Administration (FDA).

GovDelivery, Inc. sending on behalf of U.S. Food & Drug Administration (FDA) · 5600 Fishers Lane · Rockville MD 20857 · 800-439-1420